Kenya to Phase-Out Some ARV-drugs Claimed to Cause Liver Damages

By Carlos Onyango / Published October 31, 2019 | 7:17 am





The Government has announced plans to phase out some Antiretroviral drugs that are claimed to cause liver damages by December 2019.

Nevirapine, a common ARV drug used to treat most HIV positive patients will not be used again in Kenya after the phasing out is complete due to its side effects.

The phasing out of the ARVs will mostly affect children and adolescents who are at the age of 15 years and below and will take place gradually until December.

According to the acting health director Wekesa Masasabi, the affected group, that is the children and the adolescents will instead use dolutegravir (DTG) in their HIV/AIDS treatment. Adults had already been put under DTGs last year.

“Kenya will phase out Nevirapine by December 2019. All children and adolescents living with HIV currently on Nevirapine-based first-line should be transitioned to an optimal regimen,” said Dr. Masasabi.

“This rapid advice surpasses all other treatment guidelines for children and adolescents less than 15 years living with HIV who are starting treatment or are on the Nevirapine-based regimen,” he added.

The new drugs, dolutegravir (DTG) are said to be cheaper and have minimal side effects to the HIV/AIDS patients as compared to the current Neviparine drugs.

“DTG is a drug that is more effective, easier to take and has fewer side effects than alternative drugs that are currently used. DTG also has a high genetic barrier to developing drug resistance,” the WHO said in July.
Neviparine is facing resistance in many countries as patients complain about its side effects and it is even claimed to cause liver damages to some patients.

Some of the side effects of Neviparine include; rash, fatigue, headache, vomiting, diarrhea, abdominal pain, and muscle pain.

The phasing out of the ARV drugs comes just at a time when patients had started to complain that they were being given low dosages.

Patients on ARV-drugs complained that they normally receive drugs that lasted for up to three months but some facilities have been issuing drugs that last for shorter periods.

Nelson Otuoma, claims that there is no shortage of the ARVs in the country, but some facilities have not been procuring enough drugs from KEMSA leading to low dosage to patients.

“What we are experiencing is not a shortage but low dosing because some facilities have not procured enough drugs from Kemsa. This is obviously inconveniencing,” Nelson Otuoma said.






More Articles From This Author








Trending Stories










Other Related Articles










SOKO DIRECTORY & FINANCIAL GUIDE



ARCHIVES

2022
  • January 2022 (293)
  • February 2022 (329)
  • March 2022 (361)
  • April 2022 (294)
  • May 2022 (271)
  • June 2022 (178)
  • 2021
  • January 2021 (182)
  • February 2021 (227)
  • March 2021 (325)
  • April 2021 (259)
  • May 2021 (285)
  • June 2021 (273)
  • July 2021 (277)
  • August 2021 (232)
  • September 2021 (271)
  • October 2021 (305)
  • November 2021 (364)
  • December 2021 (250)
  • 2020
  • January 2020 (272)
  • February 2020 (310)
  • March 2020 (390)
  • April 2020 (321)
  • May 2020 (335)
  • June 2020 (327)
  • July 2020 (333)
  • August 2020 (276)
  • September 2020 (214)
  • October 2020 (233)
  • November 2020 (242)
  • December 2020 (187)
  • 2019
  • January 2019 (251)
  • February 2019 (215)
  • March 2019 (283)
  • April 2019 (254)
  • May 2019 (269)
  • June 2019 (249)
  • July 2019 (335)
  • August 2019 (293)
  • September 2019 (306)
  • October 2019 (313)
  • November 2019 (362)
  • December 2019 (318)
  • 2018
  • January 2018 (291)
  • February 2018 (213)
  • March 2018 (275)
  • April 2018 (223)
  • May 2018 (235)
  • June 2018 (176)
  • July 2018 (256)
  • August 2018 (247)
  • September 2018 (255)
  • October 2018 (282)
  • November 2018 (282)
  • December 2018 (184)
  • 2017
  • January 2017 (183)
  • February 2017 (194)
  • March 2017 (207)
  • April 2017 (104)
  • May 2017 (169)
  • June 2017 (205)
  • July 2017 (189)
  • August 2017 (195)
  • September 2017 (186)
  • October 2017 (235)
  • November 2017 (253)
  • December 2017 (266)
  • 2016
  • January 2016 (164)
  • February 2016 (165)
  • March 2016 (189)
  • April 2016 (143)
  • May 2016 (245)
  • June 2016 (182)
  • July 2016 (271)
  • August 2016 (247)
  • September 2016 (233)
  • October 2016 (191)
  • November 2016 (243)
  • December 2016 (153)
  • 2015
  • January 2015 (1)
  • February 2015 (4)
  • March 2015 (164)
  • April 2015 (107)
  • May 2015 (116)
  • June 2015 (119)
  • July 2015 (145)
  • August 2015 (157)
  • September 2015 (186)
  • October 2015 (169)
  • November 2015 (173)
  • December 2015 (205)
  • 2014
  • March 2014 (2)
  • 2013
  • March 2013 (10)
  • June 2013 (1)
  • 2012
  • March 2012 (7)
  • April 2012 (15)
  • May 2012 (1)
  • July 2012 (1)
  • August 2012 (4)
  • October 2012 (2)
  • November 2012 (2)
  • December 2012 (1)
  • 2011
    2010
    2009
    2008
    2007
    2006
    2005
    2004
    2003
    2002
    2001
    2000
    1999
    1998
    1997
    1996
    1995
    1994
    1993
    1992
    1991
    1990
    1989
    1988
    1987
    1986
    1985
    1984
    1983
    1982
    1981
    1980
    1979
    1978
    1977
    1976
    1975
    1974
    1973
    1972
    1971
    1970
    1969
    1968
    1967
    1966
    1965
    1964
    1963
    1962
    1961
    1960
    1959
    1958
    1957
    1956
    1955
    1954
    1953
    1952
    1951
    1950